investigators, CATALYST & Dark, P 2022, ' Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial. ', The Lancet. Respiratory medicine, vol. 10, no. 3, pp. 255-266 . https://doi.org/10.1016/S2213-2600(21)00460-4 The Lancet. Respiratory Medicine
Mwafulirwa, L, Baggs, L, Russell, J R, Hackett, C A, Morley, N, de la Fuente Cantó, C & Paterson, E 2021, ' Identification of barley genetic regions influencing plant-microbe interactions and carbon cycling in soil ', Plant and Soil, vol. 468, 468, pp. 165-182 . https://doi.org/10.1007/s11104-021-05113-6